Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Ischemic Stroke l: Introduction

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.

Ischemic Stroke ll: Pathophysiology

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

Transient Ischemic Attack l: Introduction

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...

Hemorrhagic Stroke ll: Pathophysiology

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

Hemorrhagic Stroke l: Introduction

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intracranial Aneurysm-Associated COL22A1 Variants Impair Cerebrovascular Structure and Barrier Integrity in Zebrafish.

International journal of molecular sciences·2026

Same author

Advances in Acute Ischemic Stroke 2025: Medical Treatments.

Stroke·2026

Same author

Vascular Neurology Fellowship: Where Do We Go From Here?

Stroke·2026

Same author

Transcranial Direct Current Stimulation for Stroke Motor Recovery What the TRANSPORT2 Trial Taught Us.

Stroke·2026

Same author

Apixaban Versus Aspirin and Risk of Hemorrhage in the ARCADIA Trial.

Annals of neurology·2026

Same author

Ten years of Central IRB review for an NIH-funded large clinical trial network by an academic IRB: The NIH StrokeNet experience.

Journal of clinical and translational science·2026

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Endovascular therapy for acute ischemic stroke.

Joseph P Broderick¹

¹Department of Neurology, 260 Stetson St, Suite 2300, University of Cincinnati Medical Center, PO Box, Cincinnati, OH, USA. joseph.broderick@uc.edu

|December 10, 2008

Summary

This summary is machine-generated.

Endovascular therapy shows promise for acute ischemic stroke, but reperfusion benefits diminish after 6-7 hours. Ongoing trials are crucial to confirm effectiveness and safety of new reopening methods.

Related Experiment Videos

Last Updated: Jun 27, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Area of Science:

Neurology
Interventional Cardiology
Vascular Surgery

Background:

Acute ischemic stroke treatment is rapidly evolving.
Endovascular therapy offers new approaches to restore blood flow.

Purpose of the Study:

To review recent advancements in endovascular therapy for acute ischemic stroke.
To assess the efficacy and safety of emerging endovascular techniques.

Main Methods:

Review of primate studies, randomized trials of intravenous thrombolysis, and studies on endovascular therapy.
Analysis of clinical trial data comparing endovascular methods to control treatments.

Main Results:

Endovascular therapy with thrombolytics or mechanical devices is superior to heparin alone for artery reopening.
Recanalization benefits decrease significantly after approximately 6 to 7 hours post-stroke.
Endovascular approaches have unique risk profiles, including symptomatic intracerebral hemorrhage, distinct from intravenous thrombolysis.

Conclusions:

New endovascular tools are emerging for acute ischemic stroke treatment.
Randomized trials are essential to validate the clinical effectiveness of reperfusion therapies.
Timely reperfusion remains a critical factor regardless of the chosen treatment modality.